XML 23 R62.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Information (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2020
USD ($)
segment
Mar. 31, 2019
USD ($)
Segment Reporting Information [Line Items]    
Number of reportable segments | segment 2  
Revenue, net $ 1,407 $ 1,263
Cost of revenue   1,207
Cost of revenue 1,269  
Research and development 9,444 19,643
General and administrative 6,200 7,464
Loss from operations (15,506) (27,051)
Loss from discontinued operations (258) (10,284)
Dermatology Therapeutics Segment    
Segment Reporting Information [Line Items]    
Revenue, net 218  
Research and development 9,545 19,740
Loss from operations (9,327) (19,740)
Loss from discontinued operations (257) (9,415)
Contract Research Segment    
Segment Reporting Information [Line Items]    
Revenue, net 3,407 5,190
Cost of revenue   5,037
Cost of revenue 3,386  
General and administrative 753 531
Loss from operations (732) (378)
Corporate and Other    
Segment Reporting Information [Line Items]    
Revenue, net (2,218) (3,927)
Cost of revenue   (3,830)
Cost of revenue (2,117)  
Research and development (101) (97)
General and administrative 5,447 6,933
Loss from operations (5,447) (6,933)
Loss from discontinued operations (1) (869)
Intersegment Eliminations | Contract Research Segment    
Segment Reporting Information [Line Items]    
Revenue, net $ (2,218) $ (3,927)